Ipca Labs Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for IPCA LABS LTD, and what generic and branded alternatives to IPCA LABS LTD drugs are available?
IPCA LABS LTD has twenty-nine approved drugs.
Drugs and US Patents for Ipca Labs Ltd
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ipca Labs Ltd | ATENOLOL | atenolol | TABLET;ORAL | 077877-001 | Dec 27, 2006 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Ipca Labs Ltd | RISPERIDONE | risperidone | TABLET;ORAL | 205104-003 | Jun 26, 2024 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Ipca Labs Ltd | QUETIAPINE FUMARATE | quetiapine fumarate | TABLET;ORAL | 205983-003 | May 20, 2024 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.